Clinical Trials Logo

Migraine Headache clinical trials

View clinical trials related to Migraine Headache.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05039996 Active, not recruiting - Migraine Headache Clinical Trials

Effectiveness of Education and Relaxation Program on Migraine Related Disability in Patients Attending Headache Clinic

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Migraine causes severe impairment in quality of life (QOL) both during and between attacks. Migraine also increases absenteeism, reduces productivity at work as well as at home, disrupts social and family relationships, also is associated with increased healthcare costs. The current study aiming to evaluate the effectiveness of an integrated therapeutic patient education and relaxation training intervention in order to decrease the burden of migraine headache among adult patients attending the headache clinic in Ain Shams University Hospitals.

NCT ID: NCT04584762 Active, not recruiting - Migraine Headache Clinical Trials

Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine

Start date: March 9, 2020
Phase: N/A
Study type: Interventional

Randomized, sham-controlled, double-blind study for acute migraine attacks. Randomized to active treatment and sham treatment arms for the first treatment. Optional second active treatment. Follow up at 0, 2 and 24 hours post-treatment.

NCT ID: NCT00733382 Active, not recruiting - Migraine Headache Clinical Trials

Effect of Dexamethasone on Migraine Headache

Start date: February 2008
Phase: Phase 1
Study type: Interventional

Dexamethasone is a safe and cheap abortive therapy for migraine headache. The effect of it is never evaluate and not correlate with the effect of popular anti migraine medication such as dihydroergotamine. The investigators proposal is to compare its effect with dihydroergotamine.

NCT ID: NCT00285402 Active, not recruiting - Migraine Clinical Trials

Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The purpose of this migraine prevention study is to evaluate the efficacy and safety of AST-726 in moderate to severe migraine patients at one of two doses compared to placebo and compared to a baseline period as measured by a reduction in the number of migraine days.